Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Clinical Ophthalmology (Auckland, N.Z.)
|
April 12, 2023
Three-Year Outcomes of Immediate Primary Phacoemulsification on Acute Primary Angle Closure Eyes and the Fellow Eyes
Takafumi Suzuki, Takashi Fujishiro, Naoko Tachi, et al.
Urology
|
June 3, 2008
Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004-2006
Ryosuke Ando, Teruo Nagaya, Yoshihiro Hashimoto, et al.
International Journal of Clinical Oncology
|
June 11, 2013
Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma
Taku Naiki, Noriyasu Kawai, Yoshihiro Hashimoto, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
July 28, 2011
Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score
Taku Naiki, Takehiko Okamura, Daisuke Nagata, et al.
BMJ Open Ophthalmology
|
September 26, 2022
Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion
Takafumi Suzuki, Ryo Obata, Tatsuya Inoue, et al.
Prostate International
|
March 21, 2018
Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade
Takashi Nagai, Taku Naiki, Keitaro Iida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 22, 2010
[Investigation of factors associated with time change in breath alcohol concentration after paclitaxel administration]
Ryoo Taniguchi, Norika Henmi, Riki Hirata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 19, 2010
[Prediction of gemcitabine treatment discontinuation based on platelet count before first administration]
Ryoo Taniguchi, Akira Tokutome, Jun Matsunami, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Clinical Ophthalmology (Auckland, N.Z.)
|
April 12, 2023
Three-Year Outcomes of Immediate Primary Phacoemulsification on Acute Primary Angle Closure Eyes and the Fellow Eyes
Takafumi Suzuki, Takashi Fujishiro, Naoko Tachi, et al.
Urology
|
June 3, 2008
Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004-2006
Ryosuke Ando, Teruo Nagaya, Yoshihiro Hashimoto, et al.
International Journal of Clinical Oncology
|
June 11, 2013
Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma
Taku Naiki, Noriyasu Kawai, Yoshihiro Hashimoto, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
July 28, 2011
Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score
Taku Naiki, Takehiko Okamura, Daisuke Nagata, et al.
BMJ Open Ophthalmology
|
September 26, 2022
Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion
Takafumi Suzuki, Ryo Obata, Tatsuya Inoue, et al.
Prostate International
|
March 21, 2018
Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade
Takashi Nagai, Taku Naiki, Keitaro Iida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 22, 2010
[Investigation of factors associated with time change in breath alcohol concentration after paclitaxel administration]
Ryoo Taniguchi, Norika Henmi, Riki Hirata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 19, 2010
[Prediction of gemcitabine treatment discontinuation based on platelet count before first administration]
Ryoo Taniguchi, Akira Tokutome, Jun Matsunami, et al.
Page
of 5